2018
DOI: 10.1016/j.ymgme.2017.12.035
|View full text |Cite
|
Sign up to set email alerts
|

The intra-monocyte pharmacokinetics of imiglucerase suggests a possible personalization of enzyme replacement therapy in patients with GD1

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles